Original Article

Clinical Description and Follow-up Investigation of Human West Nile Virus Cases

Authors: Kristy Gottfried, MS, Robbie Quinn, BS, Tim Jones, MD

Abstract

Objectives: The objective of this study was to investigate long-term outcomes after West Nile virus infection.


Methods: We reviewed the medical records of persons reported with West Nile virus in Tennessee in 2002 and interviewed cases 1 year after acute illness.


Results: In 2002, 56 cases of West Nile virus were reported in Tennessee; 48 (84%) had meningitis or encephalitis. Of those, 9 (19%) died during acute infection and 12 (25%) died within 6 months of illness onset. Patients with West Nile virus neurologic illness spent a median of 10 days in the hospital and were unable to resume normal activities for a median of 25 days. One year later, 12 of 22 (55%) persons reported that they were not fully recovered, with symptoms including fatigue, weakness, difficulty ambulating, and memory problems.


Conclusions: West Nile virus infection leads to high rates of mortality and substantial persistent morbidity. Prevention efforts should be targeted to populations at highest risk of severe sequelae.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Mostashari F, Bunning MS, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: Results of a household-based seroepidemiological survey. Lancet 2001;28:261–264.
 
2. Centers of Disease and Prevention. Serosurveys for WNV infection: New York and Connecticut counties, 2000. JAMA 2001;285:727–728.
 
3. Huhn G, Sejvar J, Montgomery S, et al. West Nile virus in the United States: An update on an emerging infectious disease. Am Fam Physician 2003;68:653–660.
 
4. Centers for Disease Control and Prevention. 2003. Epidemic/epizootic West Nile virus in the United States: Guidelines for surveillance, prevention, and control. 3rd revision.http://www.cdc.gov/ncidod/dvbid/westnile/resources/wnvguidelines2003.pdf Accessed January 22, 2004.
 
5. Petersen L, Marfin AA. West Nile virus: A primer for the clinician. Ann Intern Med 2002;137:173–179.
 
6. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001;344:1807–1814.
 
7. Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 2001;7:675–678.
 
8. New York Department of Health. West Nile virus surveillance and control: an update for healthcare providers in New York City. City Health Information 2001:20.
 
9. Weiss D, Carr D, Kellachan J, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 2001;7:654–658.
 
10. Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: Morbidity and mortality among patients admitted to hospital in south-central Ontario. CMAJ 2003;168:1399–1405.